Draupnir Bio
Developer of a cholesterol-lowering medicine designed to prevent blood clots in the heart more effectively than the current medicine. The company's platform technology enables the development of prote...
Valuation
$0
Share Price
N/A
Total Raised
$63.9M
Last Round
N/A